NASDAQ : VERA

Vera Therapeutics, Inc.

$38.5 USD

-$0.62 (-1.58%)

Volume
1.37M
Average Volume
1.58M
Market Capitalization
$2.76B
P/E Ratio
-6.95
Dividend Yield
0.00%
Price Target
$90.00
Year High
$56.05
Year Low
$19.07
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$13.64
3333332"{? p/.m7yd f,0=

Annual earnings financials

VERA financial data with annual/quarterly toggle

VERA GAAP EPS - Annual & Quarterly

VERA Sales Revenue - Annual & Quarterly

VERA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

VERA Estimated and Actual Revenue by Quarter
VERA Estimated and Actual EPS by Quarter
VERA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 7 - - - - - -
2027-09-30 4 - - - - - -
2027-06-30 6 - - - - - -
2027-03-31 4 - - - - - -
2026-12-31 7 - - - - - -
2026-09-30 8 - - - - - -
VERA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 7 -94.57M -8.16M -48.44M - - -
2027-09-30 4 -128.27M -11.07M -65.69M - - -
2027-06-30 6 -156.97M -13.54M -80.39M - - -
2027-03-31 4 -168.97M -14.58M -86.54M - - -
2026-12-31 7 -195.85M -16.9M -100.31M - - -
2026-09-30 8 -120.46M -96.9M -109.69M - - -
VERA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 7 36.95M 177.69M 102.55M 2 -1.32315 -0.11416 -0.67765
2027-09-30 4 28.18M 135.48M 78.19M 2 -1.79453 -0.15483 -0.91907
2027-06-30 6 20.59M 99.01M 57.14M 2 -2.19609 -0.18948 -1.12473
2027-03-31 4 15.66M 75.29M 43.45M 2 -2.36401 -0.20397 -1.21073
2026-12-31 7 8.53M 41M 23.66M 4 -2.74011 -0.23642 -1.40335
2026-09-30 8 2.38M 11.44M 6.6M 6 -1.68524 -1.35572 -1.5346